Diabetes complications

The development and progression of albuminuria in South Asians with type 2 diabetes compared with Western Europeans. Results from the HinDu the Hague diabetes study

Diabet MedPublished Retrospective cohort study

Authors' conclusion

South Asians have a higher adjusted risk to develop micro- and macroalbuminuria compared with Western Europeans. When microalbuminuria is present, time to progression from micro- to macroalbuminuria is not different between the two groups.

Study context

Population
Adults with T2D treated in a diabetes clinic in 2006 or referred thereafter (HinDu the Hague diabetes study)
Participants
1,269 vs 2,272
Exposure
South Asians vs Western Europeans with T2D
  • South Asiansn = 1,269
  • Western Europeansn = 2,272reference
Outcome
Time from diabetes diagnosis until development and progression of albuminuria (no albuminuria, persistent microalbuminuria, macroalbuminuria at end of follow-up)
Methodological detailsclosed cohort, single diabetes clinic, Cox proportional hazard models adjusted for retinopathy, hypertension, smoking and age at diabetes diagnosis
  • Closed cohort
  • Single diabetes clinic
  • Cox proportional hazard models adjusted for retinopathy, hypertension, smoking and age at diabetes diagnosis

Main finding

As reported in the abstract

South Asians vs Western EuropeansHazard ratio (95% CI)
Microalbuminuria; adjusted
1.4(1.2–1.6)
Macroalbuminuria; adjusted
1.2(1.0–1.4)

Observational data: associations, not effects.

Further findings

Mean time to progress from micro- to macroalbuminuria

Mean time to progress from micro- to macroalbuminuria

Not different between the ethnic groups

Original publication

The development and progression of albuminuria in South Asians with type 2 diabetes compared with Western Europeans. Results from the HinDu the Hague diabetes study. Diabet Med. Published 25 October 2024. doi:10.1111/dme.15454

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.